LY 366634

Drug Profile

LY 366634

Alternative Names: BDF 9196

Latest Information Update: 30 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Eli Lilly
  • Class Antiarrhythmics; Azetidines; Cardiotonics; Small molecules
  • Mechanism of Action Sodium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Heart failure

Most Recent Events

  • 04 Oct 2000 Two preclinical studies have been added to the Heart Failure pharmacodynamics section ,
  • 09 Apr 1997 New profile
  • 09 Apr 1997 Preclinical development for Heart failure in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top